Marburg virus: Difference between revisions

From IDWiki
No edit summary
()
 
(One intermediate revision by the same user not shown)
Line 25: Line 25:
*Mortality 23 to 90%
*Mortality 23 to 90%


== Diagnosis ==
==Diagnosis==


* RT-PCR at the National Microbiology Laboratory
*RT-PCR at the National Microbiology Laboratory
** Inform microbiology lab beforehand and contact Public Health for collection instructions
**Inform microbiology lab beforehand and contact Public Health for collection instructions


==Management==
==Management==
Line 35: Line 35:
*Experimental therapies include [[favipiravir]] and monoclonal antibodies
*Experimental therapies include [[favipiravir]] and monoclonal antibodies


==Prevent==
==Prevention==

===Vaccination===


*Vaccination is under investigation
*Vaccination is under investigation

===Infection Prevention and Control===

*Isolate patient
*Droplet precautions and face protection within 1 meter of patient
*Limit hospital staff who have contact


[[Category:Filoviridae]]
[[Category:Filoviridae]]

Latest revision as of 13:41, 28 August 2020

Background

Microbiology

  • Negative-sense single-stranded RNA virus in the Filoviridae family
  • Genus contains two species
    • Marburg virus
    • Ravn virus

Epidemiology

  • Rare, with 11 outbreaks since discovery in 1967, totalling 470 cases
  • Animal reservoir is fruit bat, with a sylvian cycle that occasionally spills over into human populations
    • The range of the reservoir extends into Middle East, South Asia, and south Pacific, but the virus is essentially limited to subsaharan Africa

Clinical Manifestations

  • Incubation period 2 to 21 days
  • Starts with high fever, severe headache malaise
  • Followed by multi-system involvement as early as day 3
    • Nausea, vomiting, anorexia, abdominal pain, diarrhea (can persist for a week)
    • Chest pain, dyspnea, cough
    • Hypotension, edema, maculopapular rash
    • Headache, confusion
  • Mortality 23 to 90%

Diagnosis

  • RT-PCR at the National Microbiology Laboratory
    • Inform microbiology lab beforehand and contact Public Health for collection instructions

Management

  • Good supportive care decreases mortality substantially
  • Experimental therapies include favipiravir and monoclonal antibodies

Prevention

Vaccination

  • Vaccination is under investigation

Infection Prevention and Control

  • Isolate patient
  • Droplet precautions and face protection within 1 meter of patient
  • Limit hospital staff who have contact